Explainer | Eli Lilly’s Mounjaro Enters India | Price, Dose & Everything You Need To Know Cvs Weight Management Program

In United States Publish
Post Time: 2025-07-16

US pharma giant Eli Lilly has launched Mounjaro (Tirzepatide) in India, a breakthrough drug for weight loss and type 2 diabetes management. Priced at ₹3,500 (2.5 mg) & ₹4,375 (5 mg) per vial, this once-weekly injection activates GIP & GLP-1 receptors to regulate blood sugar and reduce weight. Clinical trials show significant weight loss of up to 21.8 kg. With a high global demand, Mounjaro is set to shake up India’s booming anti-obesity and diabetes drug market, competing with Ozempic & Wegovy. Watch the full video for pricing, dosage, effectiveness. #BusinessToday #EliLily #Mounjao #WeightLossDrug #DrugMarket ----------------------- Thank You for watching! Do not forget to Like | Comment | Share ----------------------- About the channel Watch us for the best news and views on business, stock markets, crypto currencies, consumer technology, the world of real estate, bullion, automobiles, start-ups and unicorns and personal finance. Business Today TV will also bring you all you need to know about mutual funds, insurance, loans and pension plans among others. Follow us at: Website: WhatsApp: whatsapp.com/channel/0029Va4Hd309hXFCqY62yD2I Facebook: twitter: Instagram:

Explainer | Eli Lilly’s Mounjaro Enters India | Price, Dose & Everything You Need To Know For Country: United States. City: Berkeley, Denver, Detroit, Gresham, Lincoln

Tag: #Cvs Weight Management Program, #where to get saxenda, #ketozense gummies reviews, #who makes weight loss drugs, #trimova drops reviews